惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

美团技术团队
阮一峰的网络日志
阮一峰的网络日志
T
The Blog of Author Tim Ferriss
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
宝玉的分享
宝玉的分享
L
LangChain Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Last Week in AI
Last Week in AI
博客园 - 司徒正美
M
MIT News - Artificial intelligence
人人都是产品经理
人人都是产品经理
WordPress大学
WordPress大学
B
Blog RSS Feed
H
Hackread – Cybersecurity News, Data Breaches, AI and More
博客园 - Franky
B
Blog
V
V2EX
J
Java Code Geeks
D
Docker
博客园 - 叶小钗
The Cloudflare Blog
量子位
博客园_首页
MongoDB | Blog
MongoDB | Blog

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness
What Are Peptides And Why Is Everyone Talking About Them?
Dr. Sai Balasubramanian, M.D., J.D. · 2026-04-29 · via Forbes - Healthcare
Peptide therapies are being widely marketed for vitality and longevity.

Peptide therapies are being widely marketed for vitality and longevity.

getty

Peptides are, quite literally, the key building blocks of life. They are essentially short chains of amino acids, which come together to create proteins. They are akin to hormones, or chemical messengers produced by specific glands throughout the body to signal key complex processes. Notably, the body produces many natural peptides. One example that is very well known is insulin, which helps regulate body metabolism, sugar breakdown and fat storage. Another example is endorphins, which regulate mood, pain and sensation.

In recent years and especially in the last few months, influencers, models and celebrities have been touting peptides as natural supplements with claims of significantly improved bodily functions, longevity and vitality. But do they live up to the hype?

Some peptide therapies have indeed gone through rigorous clinical studies and trials before being offered to the market in actual clinical doses. Take for example the recent boom centered around GLP-1 medications, which is perhaps the most notable synthetic peptide formulation that has become popularized as a frontline therapy for obesity and appetite control. Recent statistics indicate that nearly 10 million Americans are on GLP-1 drugs, with retailers poised to get tens of millions of additional dollars in revenue per year due to the medication.

However, other peptide therapies that are frequently marketed online have not undergone serious or significant vetting. Experts indicate that the recent explosion in popularity of peptides has to be approached with caution by consumers; without consistency in dosing, insight regarding efficacy and many unknowns remaining on side effects, consumers are essentially trusting the anecdotal experience of other users.

When it comes to human metabolism and bodily functions, no two people are the same, and every single person will have a unique reaction to medications or external compounds. Sometimes, these different reactions may be so minor and hence may not even be noticeable; other times, they can lead to serious adverse effects and complications due to a person’s specific chemistry.

Take for example even something as well vetted as GLP-1 medications; while some individuals who take the medications may face no side effects, others have been reported to experience severe nausea, diarrhea, mood changes, weight loss and even significant complications such as pancreatitis and gall bladder issues.

What can be done?

Individuals interested in these new medications or therapies should keep in mind that many of them are largely unverified supplements that have not gone through rigorous vetting, standardization or regulatory controls, unlike actual FDA cleared and clinically backed prescription medications. Therefore:

  • People interested in peptides should first consult with their doctors who can offer advice and run baseline tests before starting therapy, and then monitor how it affects the body.
  • Patients should maintain frequent follow-ups with their physicians and keep a close log of any side-effects or adverse reactions.
  • Finally, especially for patients with other chronic illnesses or for those that take multiple other medications, a physician should be consulted to ensure that there are no conflicts with different medication regimens, especially with regard to pharmacokinetics. For example, certain supplements may slow down or increase the breakdown of other medications, meaning that patients will need to increase or decrease the dose to calibrate, accordingly. In certain instances, such as for blood thinners or for some medications that maintain heart rhythm, this calibration may be critical to prevent death.